Send mail to Author

Patient-reported outcomes with risankizumab versus fumaric acid esters in systemic therapy-naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _     _____     ______    _____      _____   _    _   
| |  | ||  |  ___||  /_____//  |  ___||   / ___// | || | || 
| |/\| ||  | ||__    `____ `   | ||__     \___ \\ | || | || 
|  /\  ||  | ||__    /___//    | ||__     /    // | \\_/ || 
|_// \_||  |_____||  `__ `     |_____||  /____//   \____//  
`-`   `-`  `-----`   /_//      `-----`  `-----`     `---`   
                     `-`
 


Back to frontdoor view

OPUS4 Logo